SEC Form 4 · accession 0001104659-15-066201
EPIRUS Biopharmaceuticals, Inc. · EPRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Munshi
Officer — Chief Executive Officer · Director
Period of report
Sep 18, 2015
Accepted (ET)
Sep 21, 2015 · 11:52 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001135906
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 18, 2015 | P | 10,000 | $5.986 | A | 130,453 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1All shares are held by the Amit D Munshi Revocable Trust Dated April 12, 2011, for which the Reporting Person serves as trustee.